MedPath

The effect of probiotics in treatment of patients undergoing breast cancer chemotherapy

Phase 3
Conditions
breast cancer.
Malignant neoplasm of breast
Registration Number
IRCT20191006045001N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Breast cancer without metastases
Patients candidate for chemotherapy for the first time after surgery or before surgery.
Breast cancer just diagnosed

Exclusion Criteria

Consuming probiotic supplements within 8 weeks prior to the study
Taking other forms of probiotics including probiotic yogurt and other fermented foods
Taking antioxidants supplements
Patients with metabolic syndrome
Patients with chronic infections

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life of patients. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: patient health Questionnaire 9.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath